Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: A case-series of 16 patients

Indian Journal of Dermatology, Venereology and Leprology

Volumn 78, Issue 4, 2012, Pages 448-453

  Hasson, Ariel ^a   Navarrete Dechent, Cristián ^a   Nicklas, Claudia ^a   De La Cruz, Claudia ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Actinic keratosis; organ transplant recipients; photodamage; photodynamic therapy; skin cancer ; transplant

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

ACTINIC KERATOSIS; ADULT; AGED; APPLICATION SITE PAIN; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG EFFICACY; ERYTHEMA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MULTIPLE CYCLE TREATMENT; ORGAN TRANSPLANTATION; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PROSPECTIVE STUDY; SKIN BURNING SENSATION; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

ADULT; AGED; AMINOLEVULINIC ACID; CARCINOMA, SQUAMOUS CELL; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; SCALP DERMATOSES; SKIN AGING; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864199045     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.98075     Document Type: Article

References (24)

1. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin Cancer in Organ Transplant Recipients - Where Do We Stand Today? Am J Transplant 2008;8:2192-8.
2. Donovan JC, Rosen CF, Shaw JC. Evaluation of sun-protective practices of organ transplant recipients. Am J Transplant 2004;4:1852-8.
3. Sandoval M, Ortiz M, Daz C, Majerson D, Molg M. Cutaneous manifestations in renal transplant recipients of Santiago, Chile. Transplant Proc 2009;41:3752-4.
4. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-91.
5. Dragieva G, Prinz BM, Hafner J, Dummer R, Burg G, Binswanger U, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004;151:196-200.
6. Perera GK, Child FJ, Heaton N, O'Grady J, Higgins EM. Skin lesions in adult liver transplant recipients: A study of 100 consecutive patients. Br J Dermatol 2006;154:868-72.
7. Stoff B, Salisbury C, Parker D, O'Reilly Zwald F. Dermatopathology of skin cancer in solid organ transplant recipients. Transplant Rev (Orlando) 2010;24:172-89.
8. Padilla RS, Sebastian S, Jiang Z, Nindl I, Larson R. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: A spectrum of disease progression. Arch Dermatol 2010;146:288-93.
9. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: Advances in therapy and management Part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:253-61.
10. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br J Dermatol 2002;146:552-67.
11. Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010;24:505-12.
12. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: Update. Br J Dermatol 2008;159:1245-66.
13. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: Advances in therapy and management Part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:263-79.
14. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-8.
15. Salgo R, Gossmann J, Schfer H, Kachel HG, Kuck J, Geiger H, et al. Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant 2010;10:1385-93.
16. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17.
17. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006;155:9-22.
18. Piaserico S, Belloni Fortina A, Rigotti P, Rossi B, Baldan N, Alaibac M, et al. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc 2007;39:1847-50.
19. Perrett CM, McGregor JM, Warwick J, Karran P, Leigh IM, Proby CM, et al. Treatment of post-transplant premalignant skin disease: A randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007;156:320-8.
20. de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: Results of a randomized-controlled trial. J Invest Dermatol 2006;126:569-74.
21. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006;86:25-8.
22. Carpenter PM, Linden KG, McLaren CE, Li KT, Arain S, Barr RJ, et al. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin.Cancer Epidemiol Biomarkers Prev 2004;13:1996-2002.
23. Narbutt J, Norval M, Slowik-Rylska M, Jochymski C, Kozlowski W, Sysa-Jedrzejowska A, et al. Suberythemal ultraviolet B radiation alters the expression of cell cycle-related proteins in the epidermis of human subjects without leading to photoprotection. Br J Dermatol 2009;161:890-6.
24. Bagazgoitia L, Cuevas Santos J, Juarranz A, Jan P. Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. Br J Dermatol 2011;165:144-51.